Using stable isotope dilutionlgas chromatography-mass spectrometry (IDIGC-MS), a physicochemical method, we have profiled the plasma steroids 17a-hydroxyprogesterone, 4-androstenedione, and testosterone in normal children of various age groups. Comparison of our values with those obtained by direct immunologic assays and those using an extraction or purification step showed that immunoassays in general overestimate steroid concentrations. This was especially true for plasma samples in the neonatal period and was most expressed for the concentrations of 17a-hydroxyprogesterone. Our study demonstrated the applicability of IDIGC-MS to routine clinical steroid analysis. The application of IDIGC-MS is recommended whenever problems from matrix effects or cross-reactivity are likely to arise or suspicious results by immunoassays need to be rechecked. 
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Plasma 17a-hydroxyprogesterone (17a-hydroxypregn-4-ene-3,20-dione), 4-androstenedione (androst-4-ene-3,17-dione), and testosterone (17P-hydroxyandrost-4-en-3-one) are important parameters for the diagnosis and monitoring of hyperandrogenic disorders, most importantly 21-hydroxylase deficiency (1). Currently, their routine determination is almost exclusively based on immunoassays. However, the reliability of steroid immunoassays was shown to be questionable when problems due to cross-reactivity or matrix effects are likely to arise (2-9).
To circumvent these problems, we have recently developed a method based on stable IDIGC-MS allowing the simultaneous determination of 17a-hydroxyprogesterone, 4-androstenedione, and testosterone (10). It was the purpose of this study to obtain first mass spectrometric data on the plasma concentrations of these key steroids of androgen metabolism in children of various age groups and to further demonstrate the applicability of IDJGC-MS to clinical plasma steroid analysis.
METHODS

Subjects.
We have analyzed plasma samples from 45 female and 48 male subjects. Infants and children were admitted for minor, non-endocrine disorders. Informed consent was obtained from their parents. Samples from adults were donated by staff members. The samples were collected between 0800 and 1000 h. Furthermore, 20 umbilical cord blood specimens were collected from 10 female and 10 male full-term neonates born spontaneously after an uneventful pregnancy. All blood specimens were immediately centrifuged, and the plasma was stored at -20°C until assay.
ZD/GC-MS. Plasma 17a-hydroxyprogesterone, 4-androstenedione, and testosterone were determined in a single profile according to our own IDIGC-MS procedure (10). Deuteriumlabeled analogs of the steroids-17a-hydroxy-[11,11,12,12-2 H,]progesterone, [7,7-2~2] androst-4-enedione, [16,16,17-2~,] testosterone-served as internal standards. Plasma (0.5 mL in male subjects, 0.5-2 mL in female subjects and children) was equilibrated with a cocktail containing the internal standards. After solvent extraction, the dried organic extracts were Received A U~U S~ 3, 1994; accepted January 24, 1995. purified on Sephadex LH-20 minicolumns. Then, heptafluoro- Nagel, FRG; 25 m X 0.15 mm; film thickness 0.1 pm) housed in a DAN1 6500 gas chromatograph. The gas chromatograph was directly interfaced to a Hewlett Packard 5970B mass selective detector operated in the selected ion monitoring mode. Quantitation was performed using the peak area ratios between the ion pairs of the analytes and their corresponding labeled analogs. For the steroids studied, intra-and interassay coefficients of variation were between 3.5-4.1% and 3.8-3.9%, respectively. Sensitivity was lowest for testosterone with a signal to noise ratio of 2.4 for 10 pg, and highest for 17a-hydroxyprogesterone with a signal to noise ratio of 5.3 for 10 pg. Accuracy was determined by spiking plasma with known amounts of steroids. The agreement between the values found and the amounts added was excellent with a relative error less than 7.5%. Standard plots were linear: 17a-hydroxyprogesterone, y = 1 . 8 8~ + 0.18, r = 0.999; 4-androstenedione, y = 1 . 3 7~ -0.24, r = 0.997; testosterone, y = 1 . 6 3~ -0.35, r = 0.999 (10).
RIA procedures. The umbilical cord plasma specimens were evaluated for concentrations of 17a-hydroxyprogesterone, 4-androstenedione, and testosterone both by our IDIGC-MS method and commercially available direct RIA procedures. The latter were used without and with a previous ether extraction procedure. The direct RIA assays were performed on plasma aliquots of 200 pL as described by the manufacturers using the '25~-17a-hydroxyprogesterone RIA kit from ICN Biomedicals (Costa Mesa, CA), the 125~-4-androstenedione RIA from Diagnostic System Laboratories (Webster, TX), and the 125~-testosterone RIA kit from Diagnostic Products Corporation (Bad Nauheim, FRG). Regarding the diethyl ether extraction, 200 pL of plasma were extracted with 5 mL of diethyl ether by shaking vigorously for 5 min. After freezing the aqueous phase, the supernatant was decanted and evaporated under flowing nitrogen. For assay, the sample was reconstituted in 0.5 mL of PBS. the steroid profile of an infant in whom 21-hydroxylase deficiency could be excluded. In another patient, a newborn, elevated 17a-hydroxyprogesterone could confirm 21-hydroxylase deficiency (Fig. 2) .
The concentrations of plasma 17a-hydroxyprogesterone, 4-androstenedione, and testosterone determined by IDIGC-MS in normal subjects of various age groups are summarized in Tables 1-3. 17a-Hydroxyprogesterone, 4-androstenedione, and testosterone were assayed by ID/GC-MS and direct RIA with and without ether extraction in 20 samples of cord plasma. A comparison between the results produced by the different techniques is presented in Figure 3 . The steroid values produced by ID/GC-MS were the lowest with the narrowest range. Direct RIA led to higher and more scattering steroid values. Ether extraction led to less scattering for all three hormones analyzed. A decrease in absolute steroid levels after ether extraction was noted only for 4-androstenedione and testosterone, whereas the mean levels of 17a-hydroxyprogesterone remained practically unchanged.
DISCUSSION
Currently, analytical methods based on mass spectrometry present the most specific quantitative methods for steroid determination (11, 12) . In contrast to immunoassays, a physicochemical method such as IDIGC-MS is independent of phenomena such as cross-reactivity or matrix effects. Stable isotope-labeled analogs (13) are ideally suited as internal standards because they show similar chemical behavior and offer the advantage of compensation for losses of analyte during the workup procedure. They further avoid radioactive contamination of personnel and instrumentation. Gas chromatography bears the greatest potential in determining a whole spectrum of steroid hormones simultaneouslv in a single "profile," whereas
RESULTS
RIA allow only the measurement of a single steroid at a time.
For the first time, basal plasma levels of 17a-hydroxyproApplication of our assay in a clinical setting is demonstrated gesterone, 4-androstenedione, and testosterone have been proby two examples of typical ion chromatograms: Figure 1 shows filed by IDIGC-MS in normal female and male subjects at Regarding 17a-hydroxyprogesterone, the most striking differences between our values and those determined by immunologic methods were found in cord plasma. Widely divergent plasma levels have so far been published (14-20). Using direct RIA, values as high as 203 + 37.8 nmol/L (mean + SD) in boys and 184 ? 34.5 nmol/L in girls have been reported (16). Values of comparable order were obtained using our in-house direct RIA (Fig. 3) . RIA procedures using an additional purification step such as Celite chromatography led to much lower values: 92.7 2 40.9 nmol1L in female subjects and 56.4 + 30.7 nmol/L in male subjects (14) . The values determined by ID/ GC-MS were even 4-6 times lower than the latter and did not show any significant sex difference (Table 1) . Concerning the other age groups, the 17a-hydroxyprogesterone concentrations determined by IDIGC-MS were generally up to 2 times lower than those determined by RIA techniques using a chromatographic step (14, 17, 21, 22) .
After an intense debate on the reliability of 1 7 ahydroxyprogesterone determined by direct RIA in the neonatal period and early infancy (9, (23) (24) (25) (26) (27) , it could meanwhile be demonstrated that the interference of steroid monosulfates from the fetal adrenal zone, mainly 17a-hydroxypregnenolone sulfate, can lead to false positively elevated 17a-hydroxyprogesterone levels (28). The production of steroid sulfates in the fetal adrenal zone lasts well into infancy (29). Our determinations of 17a-hydroxyprogesterone in umbilical cord plasma by direct RIA showed that l7a-hydroxypro- Note: To convert testosterone concentrations from nmol/L to ng/dL, multiply by 28.8.
* <d.l., below limit of detection. gesterone values hardly decreased after ether extraction (Fig.  3) . We conclude that an additional extraction step does not necessarily improve the diagnostic efficiency of a direct assay. As mentioned before, even inclusion of chromatographic steps can obviously not eliminate all interferences in neonatal samples. These findings bear importance regarding screening programs for 21-hydroxylase deficiency, where, for reasons of practicability, direct immunologic procedures are advantageous but are likely to produce false positively elevated results. In the case of 4-androstenedione, ID/GC-MS could not confirm the concentrations found in cord plasma using specific RIA with Celite chromatography (30). Inexplicably, the values found by ID/GC-MS (Table 2) were 2-3 times higher than the RIA values (female subjects, 3.3 t 1.30 nmol/L; male subjects, 3.0 + 0.98 nmol/L). In our experiments, direct RIA led to an overestimation of 4-androstenedione in cord blood (Fig.  3) . This tendency was less expressed as in the case of 17a-hydroxyprogesterone. The interfering factor still remains to be determined. Unlike 17a-hydroxyprogesterone, ether extraction could reduce almost all interferences. In later stages of life, no substantial differences to other series were evident (22, 30) .
17-OH-Progesterone 4-Androstenedione Testosterone
Concerning testosterone in cord plasma, the values produced by ID/GC-MS showed a much more marked sex difference than has been previously assumed (30). Again, analysis by direct RIA resulted in marked overestimation, which partially could be reduced after ether extraction (Fig. 3) . In the neonatal period, our values for males corresponded with those that have already been published (30). In female neonates, however, testosterone was undetectable by our method. Concerning later life, no gross differences to other series could be found (22, 30) .
The problems of lacking specificity and consecutive overestimation of true steroid values by immunologic methods, especially direct assays, is of particular importance not only in the newborn period and early infancy. Problems with steroid immunoassays have further been reported in prepuberty (3), in female samples (4, 5, 7), in pregnancy (4), in disorders of steroidogenesis (6, 31, 32) , or when analyzing different media, e.g. ovarian follicular fluid (2). ID/GC-MS could help circumvent these analytical problems. If the technique was used in different studies, comparability between data would not present a problem because no individual reference ranges would be needed for each immunoassay (6).
The potential of ID/GC-MS in quantitative plasma steroid analysis has not yet been exploited to its full extent. So far, ID/GC-MS has found application as a reference methodology presenting the "gold standard" for the evaluation of steroid immunoassays (12). Its use as a routine method has been lacking, however. Drawbacks concerning the use of ID/ GC-MS in a clinical setting have primarily been the huge costs
